Italia markets close in 7 hours 58 minutes

The Cooper Companies, Inc. (COO)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
337,27+3,93 (+1,18%)
Alla chiusura: 04:03PM EDT
337,27 -0,15 (-0,04%)
Dopo ore: 04:28PM EDT

The Cooper Companies, Inc.

6101 Bollinger Canyon Road
Suite 500
San Ramon, CA 94583
United States
925 460 3600
https://www.coopercos.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno12.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Albert G. White IIIPres, CEO & Non-Independent Director2,44M20,73M1970
Mr. Brian G. AndrewsExec. VP, CFO & Treasurer971k1,55M1979
Mr. Daniel G. McBride Esq.Exec. VP & COO1,44M22,77M1964
Mr. Agostino RicupatiSr. VP of Fin. & Tax and Chief Accounting Officer670,71k917,72k1967
Ms. Holly R. SheffieldPres of CooperSurgical, Inc.1,02MN/D1971
Mr. Kim DuncanVP of Investor Relations & Risk ManagementN/DN/DN/D
Mr. Nicholas S. KhadderGen. Counsel & Corp. CompanyN/DN/D1974
Mr. Juan Carlos AragonPres of CooperVision Specialty EyeCare DivisionN/DN/DN/D
Mr. Gerard H. Warner IIIPres of CooperVision, Inc.N/DN/D1965
Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Governance aziendale

L'ISS Governance QualityScore di The Cooper Companies, Inc. al 31 luglio 2022 è 4. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 4; diritti degli azionisti: 2; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.